These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I. Walther FJ, Mullett M, Schumacher R, Sundell H, Easa D, Long W. J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506 [Abstract] [Full Text] [Related]
4. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I. Gong A, Anday E, Boros S, Bucciarelli R, Burchfield D, Zucker J, Long W. J Pediatr; 1995 May; 126(5 Pt 2):S68-74. PubMed ID: 7745514 [Abstract] [Full Text] [Related]
5. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I. Sell M, Cotton R, Hirata T, Guthrie R, LeBlanc M, Mammel M, Long W. J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507 [Abstract] [Full Text] [Related]
6. Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactant. American Exosurf Neonatal Study Groups I and II. Gerdes J, Gerdes M, Beaumont E, Cook L, Dhanireddy R, Kopleman A, Jarret R, Long W. J Pediatr; 1995 May; 126(5 Pt 2):S26-32. PubMed ID: 7745508 [Abstract] [Full Text] [Related]
10. Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I. Corbet A, Long W, Schumacher R, Gerdes J, Cotton R. J Pediatr; 1995 May; 126(5 Pt 2):S5-12. PubMed ID: 7745511 [Abstract] [Full Text] [Related]
12. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa. Corbet A, Gerdes J, Long W, Avila E, Puri A, Rosenberg A, Edwards K, Cook L. J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110 [Abstract] [Full Text] [Related]
16. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. Bose C, Corbet A, Bose G, Garcia-Prats J, Lombardy L, Wold D, Donlon D, Long W. J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698 [Abstract] [Full Text] [Related]
19. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. Dechant KL, Faulds D. Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378 [Abstract] [Full Text] [Related]